Last updated on November 2018

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.


Brief description of study

EP0060 is a multicenter, open-label study to evaluate the safety and tolerability of intravenous (iv) Lacosamide (LCM) in pediatric subjects >= 1 month to < 17 years of age with epilepsy.

Clinical Study Identifier: NCT02710890

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Ep0060 141
Radeberg, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.